About Conatus Pharmaceuticals, Inc.

Conatus Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of medicines for the treatment of liver diseases. It focuses in development of emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease, which reduce the activities of human caspases. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.

At the moment the company generates 35M USD in revenues.

On its last earning announcement, the company reported a loss of -0.62$ per share.

The book value per share is 0.66$

Conatus Pharmaceuticals, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
35M - -19M -53.40% -18M -0.62 - - 30M 0.66 -36M - -36M